PUMA BIOTECHNOLOGY, INC. Deferred Income Tax Assets, Net
PUMA BIOTECHNOLOGY, INC. (PBYI) had Deferred Income Tax Assets, Net of $3.83 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Assets, Net $3.83M.
- 2026-03-31: Deferred Income Tax Assets, Net $3.83M.
- 2025-12-31: Deferred Income Tax Assets, Net $3.83M.
- 2025-09-30: Deferred Income Tax Assets, Net $7.08M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $3.83M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.83M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.83M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $7.08M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $7.08M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $7.08M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.08M 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |